December 14, 2022 the CDC released a HAN Health Advisory regarding Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir.

Find out more at: https://emergency.cdc.gov/han/2022/han00482.asp